VEGFA and neoplasm: A critical occurrence leading to the success or failure of anti-angiogenic therapy is the need for a proper timing window for tumor vascular normalization: long term anti-angiogenic therapy sometimes leads to tumor hypoxia (Winkler et al., 2004), and hypoxia triggers VEGF production, genetic instability in tumor ECs and vascular permeability (Taylor et al., 2010).